alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1806 Introduced in Senate (IS)]

104th CONGRESS
  2d Session
                                S. 1806

 To amend the Federal Food, Drug, and Cosmetic Act to clarify that any 
    dietary supplement that claims to produce euphoria, heightened 
 awareness or similar mental or psychological effects shall be treated 
            as a drug under the Act, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 23, 1996

   Mr. D'Amato (for himself, Mr. Dodd, and Mr. Frist) introduced the 
 following bill; which was read twice and referred to the Committee on 
                       Labor and Human Resources

_______________________________________________________________________

                                 A BILL

 
 To amend the Federal Food, Drug, and Cosmetic Act to clarify that any 
    dietary supplement that claims to produce euphoria, heightened 
 awareness or similar mental or psychological effects shall be treated 
            as a drug under the Act, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DEFINITION OF DRUG.

    Section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 321(g)(1)) is amended by adding at the end thereof the following 
new sentence: ``Notwithstanding the preceding sentence, a dietary 
supplement shall be considered a drug under clause (C) if the label or 
labeling of such drug claims or implies that the dietary supplement 
produces euphoria, heightened awareness, or similar mental or 
psychological effects.''.
                                 <all>
```
<TABLE>
<CAPTION>
                                                                  UGLY DUCKLING CORPORATION
                                                  SCHEDULE OF COMPUTATION OF EARNINGS PER COMMON SHARE
                                                                 Year  Ended December 31,
                                      ----------------------------------------------------------------------------------
                                                 1996                       1995                         1994
                                      ------------------------    -------------------------   --------------------------
                                                      Fully                       Fully                      Fully
                                       Primary       Diluted       Primary       Diluted      Primary       Diluted
                                      -----------  -----------   ------------  ------------   ------------  ------------
<S>                                   <C>          <C>           <C>           <C>            <C>           <C>
Net earnings (loss)                   $5,866,000   $5,866,000    $(3,972,000)  $(3,972,000)   $(1,967,000)  $(1,967,000)
Preferred dividends                     (916,000)    (916,000)             0             0              0             0
                                      ----------   -----------   ------------  ------------   ------------  ------------
 Net earnings (loss)available to
   common shares                      $4,950,000   $4,950,000    $(3,972,000)  $(3,972,000)   $(1,967,000)  $(1,967,000)
                                      ===========  ===========   ============  ============   ============  ============

Earnings (loss) per common share      $     0.60   $   0.60(a)   $     (0.67)  $     (0.67)   $     (0.35)  $     (0.35)
                                      ===========  ===========   ============  ============   ============  ============

Weighted average common shares
   outstanding                        $7,887,000   $7,887,000    $ 5,522,000   $ 5,522,000    $ 5,214,000   $ 5,214,000
Common equivalent shares outstanding
  using the treasury stock method        396,000      430,000        370,000       370,000        370,000       370,000
                                      -----------  -----------   ------------  ------------   ------------  ------------

Weighted average common and common
  equivalent shares outstanding       $8,283,000   $8,317,000    $ 5,892,000   $ 5,892,000    $ 5,584,000   $ 5,584,000
                                      ===========  ===========   ============  ============   ============  ============
</TABLE>



(a)  This  calculation is submitted in accordance with Regulation S-K item
     601(b)(11) although not required by footnote 2 to paragraph 14 of APB
     Opinion No. 15 because it results in dilution of less than 3%
















<PAGE>  121
* Pursuant to 5TH CIR. R. 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5TH CIR. R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 98-40510

Summary Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellant,

versus

MOISES CORDERO-GODINEZ,

Defendant-Appellee.

- - - - - - - - - -

Appeal from the United States District Court

for the Southern District of Texas

USDC No. M-97-CR-374-1

- - - - - - - - - -

March 9, 1999

Before HIGGINBOTHAM, JONES, and DENNIS, Circuit Judges.

PER CURIAM:*

Moises Cordero-Godinez was convicted for attempting

illegally to enter the United States after having been previously

deported in violation of 8 U.S.C. § 1326(a). Cordero has appealed

his sentence, which was enhanced under 8 U.S.C. § 1326(b)(2).

Cordero contends for the first time on appeal that the district

court erred in enhancing Cordero’s sentence pursuant to

§ 2L1.2(b)(1)(A) because the definition of “aggravated felony” in

8 U.S.C. § 1101(a)(43)(G) is unconstitutionally vague as applied to

him. Because this issue was not raised in the district court, we
No. 98-40510

-2-

review it for plain error only. See United States v. Spires, 79

F.3d 464, 465-66 (5th Cir. 1996); see also United States v.

Knowles, 29 F.3d 947, 950-51 (5th Cir. 1994) (alleged constitutional error in criminal conviction reviewed for plain error).

This court does not follow contrary authority from other circuits.

see, e.g., U.S. v. Tabocca, 924 F.2d 906, 912 (9th Cir. 1991). To

demonstrate plain error, an appellant must show clear or obvious

error that affects his substantial rights; if he does, this court

has discretion to correct a forfeited error that seriously affects

the fairness, integrity, or public reputation of judicial

proceedings, but is not required to do so. United States v.

Calverley, 37 F.3d 160, 162-64 (5th Cir. 1994) (en banc) (citing

United States v. Olano, 507 U.S. 725, 730-35 (1993)). 

The Federal Public Defender does no service to the courts

or its client when it raises issues like this for the first time on

appeal. Bound as we are by Olano, we are not required to express

a view on the merits of appellant’s challenge except to note that

it is highly dubious that the vagueness doctrine applies to

sentencing statutes that merely pertain to “the statutory range

[within which] the guideline sentence will fall.” United States v.

Pearson, 910 F.2d 221, 223 (5th Cir. 1990). Moreover, there is no

adverse effect on this appellant’s substantial rights, nor does his

sentence reflect adversely on the fairness, integrity or public

adversely perception of judicial proceedings.

AFFIRMED.
<PAGE>


                                                                    Exhibit 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS
                       ----------------------------------

We hereby consent to the incorporation by reference in the Registration
Statements on Form S-3 (Nos. 333-38079, 333-49295, 333-49433, 333-60785,
333-61474, 333-62748, 333-65735, 333-65793, 333-72681, 333-80735, and 333-86797)
and Form S-8 (Nos. 333-20329, 333-68520, 333-79623) of Prentiss Properties Trust
of our report dated February 6, 2002, except as to Note 23, for which the date
is March 7, 2002 relating to the financial statements and financial statement
schedule, which appears in this Form 10-K. We also consent to the reference to
us under the caption "Selected Financial Data" in such Form 10-K.




/s/ PricewaterhouseCoopers LLP


Dallas, Texas
March 25, 2002
#### CENTOCOR, INC., the Trustees of Columbia University in the City of New York, and the Board of Trustees of the Leland Stanford Junior University, Plaintiffs-Appellants, v. MEDIMMUNE, INC., Defendant-Appellee.

No. 02-1118.

United States Court of Appeals, Federal Circuit.

DECIDED: Jan. 28, 2003.

ORDER

The parties having so agreed, it is

ORDERED that the proceeding is DISMISSED under Fed. R.App. P. 42(b).
| Exhibit 32.2 |
|--------------|

| SECTION 1350 CERTIFICATIONS |
|-----------------------------|
| OF                          |
| EXPRESSJET HOLDINGS, INC.   |

I, Frederick S. Cromer, Vice President and Chief Financial Officer of ExpressJet Holdings, Inc., certify, pursuant to Section906 of the Sarbanes-Oxley Act of 2002 (subsections (2) and (b) of Section 1350, Chapter 63 of Title 18, United States Code),that:

| (1)   | the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2004 (the “Periodic Report”) which thisstatement accompanies fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15U.S.C. 78m or 78o(d)) and |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)   | information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results ofoperations of ExpressJet Holdings, Inc.                                                                                                                  |

This certificate is being furnished solely for purposes of Section 906 and is not being filed as part of the PeriodicReport.

|  Date:  April 16,2004                 |              | **/s/ Frederick S.Cromer                         ** |
|--------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                   | Frederick S. Cromer Vice President and Chief Financial Officer           |

----
## In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02

- 23

- 00017

- CV

I N THE I NTEREST OF S.B. AND K.B.,

C HILDREN §

§

§

§ On Appeal from the 360th District

Court

of Tarrant County ( 36 0

- 684 420

- 20 )

October 5, 2023

Memorandum Opinion by Justice

Bassel

JUDGMENT

This court has considered the record on appeal in this case and holds that there

was error in the trial court’s order . The final order is modified so that the wording

matches the n umer ic amount of unpaid child suppo rt owed b y Appellant Father :

“ One Thou sand Four Hund red Thirty

- Seven dollars and Eight cents ($1,437.08). ” It

is ordered that the final order of the trial court is affirmed as modified.

SECOND DISTRICT COURT OF APPEALS

By /s/ Dabney Bassel

Justice Dabney Bassel
104TH CONGRESS

2D SESSION S. 2197

AN ACT

To extend the authorized period of stay within the United

States for certain nurses.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

S 2197 ES

1 SECTION 1. EXTENSION OF AUTHORIZED PERIOD OF STAY

2 FOR CERTAIN NURSES.

3 (a) ALIENS WHO PREVIOUSLY ENTERED THE UNIT4 ED STATES PURSUANT TO AN H–1A VISA.—

5 (1) IN GENERAL.—Notwithstanding any other

6 provision of law, the authorized period of stay in the

7 United States of any nonimmigrant described in

8 paragraph (2) is hereby extended through September

9 30, 1997.

10 (2) NONIMMIGRANT DESCRIBED.—A non11 immigrant described in this paragraph is a non12 immigrant—

13 (A) who entered the United States as a

14 nonimmigrant described in section

15 101(a)(15)(H)(i)(a) of the Immigration and

16 Nationality Act;

17 (B) who was within the United States on

18 or after September 1, 1995, and who is within

19 the United States on the date of the enactment

20 of this Act; and

21 (C) whose period of authorized stay has ex22 pired or would expire before September 30,

23 1997 but for the provisions of this section.

24 (3) LIMITATIONS.—Nothing in this section may

25 be construed to extend the validity of any visa issued

26 to a nonimmigrant described in section
3

S 2197 ES

1 101(a)(15)(H)(i)(a) of the Immigration and Nation2 ality Act or to authorize the re-entry of any person

3 outside the United States on the date of the enact4 ment of this Act.

5 (b) CHANGE OF EMPLOYMENT.—A nonimmigrant

6 whose authorized period of stay is extended by operation

7 of this section shall not be eligible to change employers

8 in accordance with section 214.2(h)(2)(i)(D) of title 8,

9 Code of Federal Regulations (as in effect on the day be10 fore the date of the enactment of this Act).

11 (c) REGULATIONS.—Not later than 30 days after the

12 date of the enactment of this Act, the Attorney General

13 shall issue regulations to carry out the provisions of this

14 section.

15 (d) INTERIM TREATMENT.—A nonimmigrant whose

16 authorized period of stay is extended by operation of this

17 section, and the spouse and child of such nonimmigrant,

18 shall be considered as having continued to maintain lawful

19 status as a nonimmigrant through September 30, 1997.

20 SEC. 2. TECHNICAL CORRECTION.

21 Effective on September 30, 1996, subtitle A of title

22 III of the Illegal Immigration Reform and Immigrant Re23 sponsibility Act of 1996 is amended—

24 (1) in section 306(c)(1), by striking ‘‘to all

25 final’’ and all that follows through ‘‘Act and’’and in-
4

S 2197 ES

1 serting ‘‘as provided under section 309, except

2 that’’;

3 (2) in section 309(c)(1), by striking ‘‘as of’’ and

4 inserting ‘‘before’’; and

5 (3) in section 309(c)(4), by striking ‘‘described

6 in paragraph (1)’’.

Passed the Senate October 3, 1996.

Attest:

Secretary.
104TH CONGRESS

2D SESSION S. 2197

AN ACT

To extend the authorized period of stay within the

United States for certain nurses.
### THE THIRTEENTH COURT OF APPEALS

13

- 17

- 00088

- CR
Johnny Anthony Palomo

v. The State of Texas

On a ppeal from the 93rd District Court of Hidalgo County , Texas Trial Cause No. CR

- 0768

- 15

- B

JUDGMENT THE THIRTEENTH COURT OF APPEALS, having considered thi s cause on appeal, concludes that the judgment of the trial court should be affirmed . The Court orders the judgment of the trial court AFFIRMED

. We further order this decision certified below for observance. October 25, 2018
MEMORANDUM

From: The United States Environmental Protection Agency

To: EGU NSPS Docket (EPA-HQ-OAR-2013-0602)

Date: October 2014

Subject: Clarification of Docket Datasets in GHG Abatement Measures Technical Support 

Document

Introduction

The purpose of this memorandum is to make clarifying edits to the table titled Docket Datasets on page 

2-41 of the GHG Abatement Measures Technical Support Document (EPA-HQ-OAR-2013-0602-0437). 

The EPA has revised the table to clarify the names and descriptions of the data files referenced in the 

table.

Clarification to Docket Datasets table

Name Description

Dataset related to 

Chapter 2 of the GHG 

Abatement Measures 

TSD (EPA-HQ-OAR2013-0602-0238)

2002-2012 hourly dataset, including data for regression analysis and unityear binned results at 10-50% difference options

GHG Abatement 

Measures Hourly Unit 

Data Column 

Descriptions (EPA-HQOAR-2013-0602-0237)

Description of the data columns in the Dataset related to Chapter 2 of the 

GHG Abatement Measures TSD

GHG Abatement 

Measures Unit Study 

Population (EPA-HQOAR-2013-0602-0239)

Information about units included in the analysis described in the GHG 

Abatement Measures TSD (see units with “Y” in the “In Study” column)
<PAGE>
Exhibit 32.2 Certification pursuant to Section 906 of the Sarbanes-Oxley Act of
2002

I, James Mitchell, Chief Financial Officer of Family Home Health Services Inc.
(the "registrant"), have executed this certification for furnishing to the
Securities and Exchange Commission in connection with the filing with the
Commission of the registrant's Quarterly Report on Form 10-Q for the period
ended September 30, 2005 (the "Report"). I hereby certify that:

          (1) the Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

          (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the of
the registrant as of and for the end of that period.


November 14, 2005                        /s/ James Mitchell
                                         ---------------------------------------
                                         James Mitchell
                                         Chief Financial Officer
```

[Federal Register: March 29, 2010 (Volume 75, Number 59)]
[Notices]               
[Page 15419]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29mr10-43]                         

=======================================================================
-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION

 
Sunshine Act Meetings

Time and Date: Wednesday, March 31, 2010, 9 a.m.-12 Noon.

Place: Hearing Room 420, Bethesda Towers, 4330 East West Highway, 
Bethesda, Maryland.

Status: Commission Meeting--Open to the Public.

Matter To Be Considered

    1. Pending Decisional Matter: Definition of Children's Product--
Notice of Proposed Rulemaking (NPR).
    A live Web cast of the Meeting can be viewed at http://www.cpsc.gov/webcast/index.html.
    For a recorded message containing the latest agenda information, 
call (301) 504-7948.

Contact Person for More Information: Todd A. Stevenson, Office of the 
Secretary, U.S. Consumer Product Safety Commission, 4330 East West 
Highway, Bethesda, MD 20814 (301) 504-7923.

    Dated: March 24, 2010.
Todd A. Stevenson,
Secretary.
[FR Doc. 2010-6943 Filed 3-25-10; 11:15 am]
BILLING CODE 6355-01-P
```
**Exhibit32.2**

 

STATEMENT OF CHIEF FINANCIALOFFICERPURSUANT TO SECTION 906 OFTHE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 906 of the Sarbanes-OxleyAct of 2002, I, Thomas R. Moyes, certify that:

 

1.  The Quarterly Report on Form 10-QSB for thequarter ended September 30, 2004 (the “Report”) of MediCor Ltd. (the “Company”),fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

2.  The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of MediCor.

 

Date: November 15, 2004

 

 
|   | /s/ Thomas R. Moyes     |   |
|--------|-------------------------|--------|
|   | Thomas R. Moyes         |
|   | Chief Financial Officer |

 

----
<PAGE>   1
                                                                    EXHIBIT 24.4


                            SPECIAL POWER OF ATTORNEY
                             (for Arturo R. Moreno)


KNOW ALL MEN BY THESE PRESENTS, that the undersigned constitutes and appoints
Ernest C. Garcia II, Gregory B. Sullivan, and Steven T. Darak, and Steven P.
Johnson, and each of them, his true and lawful attorney-in-fact and agent with
full power of substitution and resubstitution, for him and in his name, place,
and stead, in any and all capacities, to sign the Annual Report on Form 10-K for
the fiscal year ended December 31, 1997, for filing with the Securities and
Exchange Commission ("SEC") by Ugly Duckling Corporation, a Delaware
corporation, together with any and all amendments to such Form 10-K, and to file
the same with all exhibits thereto, and all documents in connection therewith,
with the SEC, granting to such attorneys-in-fact and agents, and each of them,
full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully and to
all intents and purposes as he might or could do in person, hereby ratifying and
confirming all that such attorneys-in-fact and agents, or each of them, may
lawfully do or cause to be done by virtue hereof.


DATE: February 6 1998




                                          /s/ ARTURO R. MORENO
Exhibit
      31.1


**CERTIFICATIONS**





I,
      Joshua
      D. Schein, Ph.D. certify that:





1)
      I have
      reviewed this amended quarterly report on Form 10-QSB/A of Lev Pharmaceuticals,
      Inc.; and





2)
      Based
      on my knowledge, this quarterly report does not contain any untrue statement
      of
      a material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were
      made, not misleading with respect to the period covered by this quarterly
      report.





Date:
                August 27, 2007
            
            /s/
                Joshua D. Schein, Ph.D.Joshua
                D. Schein, Ph.D.Chief
                Executive Officer
<PAGE>

                        CONSENT OF INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration Statements
on Form S-8 No. 333-34074 pertaining to the Deferred Bonus Plan (the "Plan")
for the registration of $1,500,000 of its deferred compensation obligation
pursuant to the Plan, Form S-8 No. 333-09729 pertaining to the 1996 Stock
Incentive Plan and Form S-8 No. 333-58171 pertaining to the 1996 Non-Employee
Director Stock Option Plan of Donna Karan International Inc. of our report
dated March 13, 2001, except for Note 18 as to which the date is April 2,
2001, with respect to the consolidated financial statements and schedule of
Donna Karan International included in its Annual Report (Form 10-K) for the
year ended December 31, 2000.

                                        /s/ Ernst & Young LLP

New York, New York
March 29, 2001